Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) FCF Margin (2016 - 2025)

Vycor Medical has reported FCF Margin over the past 16 years, most recently at 9.03% for Q4 2025.

  • Quarterly FCF Margin rose 1743.0% to 9.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.81% through Dec 2025, down 459.0% year-over-year, with the annual reading at 1.0% for FY2025, 445.0% down from the prior year.
  • FCF Margin was 9.03% for Q4 2025 at Vycor Medical, up from 14.1% in the prior quarter.
  • Over five years, FCF Margin peaked at 21.18% in Q2 2024 and troughed at 25.1% in Q1 2022.
  • The 5-year median for FCF Margin is 2.47% (2023), against an average of 3.22%.
  • Year-over-year, FCF Margin surged 4228bps in 2021 and then crashed -2449bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 11.61% in 2021, then crashed by -205bps to 12.18% in 2022, then surged by 99bps to 0.13% in 2023, then plummeted by -6445bps to 8.41% in 2024, then soared by 207bps to 9.03% in 2025.
  • Per Business Quant, the three most recent readings for VYCO's FCF Margin are 9.03% (Q4 2025), 14.1% (Q3 2025), and 9.4% (Q2 2025).